EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 161 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $248,579 | -47.4% | 12,787 | -23.3% | 0.00% | -50.0% |
| Q1 2023 | $472,843 | +1.3% | 16,667 | +4.4% | 0.00% | 0.0% |
| Q4 2022 | $466,803 | +12.2% | 15,970 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $416,000 | -52.3% | 15,745 | -19.9% | 0.00% | -42.9% |
| Q2 2022 | $873,000 | -0.5% | 19,655 | +10.8% | 0.01% | +40.0% |
| Q1 2022 | $877,000 | +5.4% | 17,732 | +8.6% | 0.01% | +25.0% |
| Q4 2021 | $832,000 | -38.0% | 16,330 | -32.1% | 0.00% | -50.0% |
| Q3 2021 | $1,342,000 | +85.9% | 24,057 | +42.6% | 0.01% | +100.0% |
| Q2 2021 | $722,000 | +248.8% | 16,871 | +290.6% | 0.00% | +100.0% |
| Q2 2020 | $207,000 | -96.4% | 4,319 | -96.5% | 0.00% | -96.6% |
| Q1 2020 | $5,725,000 | -23.9% | 124,463 | -0.6% | 0.06% | +3.6% |
| Q4 2019 | $7,520,000 | +9.2% | 125,166 | +2.8% | 0.06% | +1.8% |
| Q3 2019 | $6,887,000 | +1.1% | 121,746 | -0.5% | 0.06% | 0.0% |
| Q2 2019 | $6,813,000 | +10.2% | 122,368 | -0.1% | 0.06% | +10.0% |
| Q1 2019 | $6,183,000 | +23.1% | 122,456 | -1.8% | 0.05% | +16.3% |
| Q4 2018 | $5,022,000 | -17.2% | 124,643 | +42.5% | 0.04% | +7.5% |
| Q3 2018 | $6,064,000 | -31.2% | 87,469 | -24.9% | 0.04% | -32.2% |
| Q2 2018 | $8,811,000 | -12.3% | 116,451 | -38.9% | 0.06% | +136.0% |
| Q1 2018 | $10,049,000 | +38.1% | 190,705 | +40.0% | 0.02% | +47.1% |
| Q4 2017 | $7,276,000 | -13.9% | 136,196 | -3.9% | 0.02% | -15.0% |
| Q3 2017 | $8,449,000 | -19.0% | 141,662 | +7.2% | 0.02% | -28.6% |
| Q2 2017 | $10,428,000 | +231.8% | 132,173 | +248.9% | 0.03% | +211.1% |
| Q1 2017 | $3,143,000 | +0.8% | 37,883 | -3.5% | 0.01% | 0.0% |
| Q4 2016 | $3,117,000 | -40.7% | 39,275 | -47.7% | 0.01% | -43.8% |
| Q3 2016 | $5,256,000 | +223.6% | 75,089 | +79.4% | 0.02% | +220.0% |
| Q2 2016 | $1,624,000 | +8.8% | 41,855 | +13.6% | 0.01% | 0.0% |
| Q1 2016 | $1,492,000 | -20.0% | 36,850 | +75.1% | 0.01% | 0.0% |
| Q4 2015 | $1,866,000 | +14.9% | 21,046 | -4.1% | 0.01% | 0.0% |
| Q3 2015 | $1,624,000 | – | 21,935 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 113,737 | $3,227 | 0.98% |
| Smith, Graham & Co., Investment Advisors, LP | 236,883 | $6,720,371 | 0.82% |
| Capital Impact Advisors, LLC | 13,607 | $386,031 | 0.47% |
| TANG CAPITAL MANAGEMENT LLC | 80,000 | $2,269,600 | 0.34% |
| BRANDES INVESTMENT PARTNERS, LP | 545,050 | $15,463,069 | 0.33% |
| Watershed Asset Management, L.L.C. | 9,496 | $269,402 | 0.33% |
| Jackson Creek Investment Advisors LLC | 25,164 | $714 | 0.30% |
| SummerHaven Investment Management, LLC | 18,178 | $515,710 | 0.30% |
| Virtus Fund Advisers, LLC | 1,117 | $31,689 | 0.22% |
| Virtus Investment Advisers, Inc. | 7,308 | $207,328 | 0.14% |